Literature DB >> 15933654

The working alliance in pediatric chronic disease management: a pilot study of instrument reliability and feasibility.

Beth Ely1, Leslie B Alexander, Monica Reed.   

Abstract

Findings are presented from a pilot study to determine the reliability, relevance, and feasibility of child and adult versions of the Working Alliance Inventory, adapted from psychotherapy research for use in the management of chronic childhood hematologic disorders. Thirty-four children, 13 adolescents, 43 parent/guardians, and 4 health-care providers participated. The adapted scales, called the Working Alliance Inventories for Chronic Care, had strong internal consistencies for all versions; retest reliabilities were generally acceptable. The instruments were feasible to use and understandable for children 9 years and older, parent/guardians, and health-care professionals. Recommendations for additional research, using this promising group of alliance instruments, are provided.

Entities:  

Mesh:

Year:  2005        PMID: 15933654     DOI: 10.1016/j.pedn.2005.01.007

Source DB:  PubMed          Journal:  J Pediatr Nurs        ISSN: 0882-5963            Impact factor:   2.145


  3 in total

1.  Development and feasibility of a self-management intervention for chronic obstructive pulmonary disease delivered with motivational interviewing strategies.

Authors:  Roberto Benzo; Kristin Vickers; Denise Ernst; Sharon Tucker; Charlene McEvoy; Kate Lorig
Journal:  J Cardiopulm Rehabil Prev       Date:  2013 Mar-Apr       Impact factor: 2.081

2.  The Working Alliance Inventory's Measurement Properties: A Systematic Review.

Authors:  Davy Paap; Yasmaine H J M Karel; Arianne P Verhagen; Pieter U Dijkstra; Jan H B Geertzen; Grieteke Pool
Journal:  Front Psychol       Date:  2022-07-15

Review 3.  Measuring therapeutic relationship in the care of patients with haemophilia: A scoping review.

Authors:  Erin McCabe; Maxi Miciak; Liz Dennett; Patricia Manns; Christine Guptill; Jeremy Hall; Douglas P Gross
Journal:  Health Expect       Date:  2018-08-29       Impact factor: 3.377

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.